Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/25 16:25 | 9/2/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Blum Robert I | CA | DO | P,CEO | 6 | S | -1,574 | 52.48 | 0 | -30 | 387 | D | |||||||||||||||
10/27/25 17:59 | 10/27/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Wierenga Wendell | CA | D | 2 | M.d | 300 | 34.34 | 0 | 9 | 37 | 32 | D | |||||||||||||||
10/27/25 17:59 | 10/27/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Wierenga Wendell | CA | D | 2 | S.d | -300 | 34.34 | 0 | -9 | 32 | D | ||||||||||||||||
10/21/25 18:18 | 9/9/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 12 | M.d | 722 | 29.84 | 0 | 24 | 21 | 141 | D | ||||||||||||||
10/21/25 18:18 | 9/9/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Malik Fady Ibraham | CA | O | EVP Rese | 12 | S.d | -722 | 29.84 | 0 | -24 | 141 | D | |||||||||||||||
10/6/25 16:27 | 9/2/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Kaye Edward M. Md | CA | D | 3 | S | -1,112 | 55.03 | 0 | -20 | 23 | D | ||||||||||||||||
9/2/25 16:34 | 9/2/25 | CYTK | Health | Drug | Pharmaceutical Preparations | Harrington Robert Arthur | CA | D | 1 | S | -105 | 48.67 | 0 | -2 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |